Webinars and Videos

In this episode of "In the Interim…", host Dr. Scott Berry is true to the name of the podcast, as he discusses the unblinded world of adaptive clinical trials alongside Dr. Roger Lewis, a renowned expert in both statistical science and clinical medicine.

In this FACTS webinar, the Berry Consultants team unveils FACTS 7.1.1, showcasing important updates to our statistical software for clinical trial design.

Multiple Berry Consultants team members will be presenting in a range of innovative clinical trial sessions at the upcoming Society of Clinical Trials (SCT) 46th Annual Meeting in Vancouver, British Columbia, Canada on May 18-21.

In the latest episode of "In the Interim...", Dr. Scott Berry and Dr. Mike Krams sit down with Dr. Husseini Manji, to explore the potential of platform trials in advancing precision medicine within psychiatry, particularly in tackling complex mental illnesses.

In Episode 11 of "In the Interim...", host Scott Berry discusses the nuances of implementing adaptive clinical trials with Dr. Anna McGlothlin and Dr. Michelle Detry from Berry Consultants.

In this episode of "In the Interim..." we revisit the ground-breaking seamless phase 2/3 clinical trial for the GLP-1 agonist, dulaglutide—better known as Trulicity.